YAP1 and non-small cell lung carcinoma: In osimertinib-resistant PC-9/AR NSCLC cells, knockdown of YAP1 by shRNA could decrease the IC50 value of cells to 0.5μmol/L, showing the implication of YAP1 in osimertinib resistance (Figure 2A-C).